NFKB1 and acute lymphoblastic leukemia: Together with bioinformatics analysis and Western blot verification, we found that ALL reduced the accumulation of upstream chemokine CX3CL1 to inhibit NF-κB and apoptosis pathways to achieve anti-inflammatory action and regulated tight-junction proteins occludin and claudin-1 to repair the intestinal barrier in the colon.